Literature DB >> 15383750

Review of the quality of life and burden of illness in gastroesophageal reflux disease.

Ingela Wiklund1.   

Abstract

Gastroesophageal reflux disease (GERD) is associated with a range of symptoms (typically heartburn, acid regurgitation and dysphagia), which may or may not be accompanied by endoscopically evident esophagitis. A number of studies have demonstrated that health-related quality of life (HRQoL) in reflux disease patients is significantly impaired in comparison to the general population, regardless of the endoscopic findings. Furthermore, this impairment is comparable to or greater than that observed in other chronic conditions, such as diabetes, arthritis or congestive heart failure. Impaired HRQoL in GERD patients is a result of features such as disturbed sleep, reduced vitality, generalized body pain, an impaired sex life and anxiety about the underlying cause of the symptoms. Nocturnal symptoms of reflux disease appear to have a particularly marked impact on HRQoL. The burden of illness imposed by reflux disease on HRQoL also has an impact on productivity, both at and outside work. The impact of reflux disease on productivity is significant and comparable to that caused by headache or back pain. Effective treatment is available for reflux disease, and there is evidence that this can quickly restore HRQoL to levels observed in the general population. However, poor communication between physicians and patients is contributing to unacceptable levels of patient dissatisfaction. Understanding patients' experience of GERD and its treatment through the study of HRQoL is one way to address this problem. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15383750     DOI: 10.1159/000080308

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  58 in total

1.  Comparison of presentation and impact on quality of life of gastroesophageal reflux disease between young and old adults in a Chinese population.

Authors:  Shou-Wu Lee; Chia-Ming Chang; Chi-Sen Chang; Ai-Wen Kao; Ming-Chih Chou
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

Review 2.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

3.  Acid control cannot be improved with a modified-release formulation of a proton pump inhibitor compared with twice-daily dosing of the conventional formulation.

Authors:  Kerstin Röhss; Clive Wilder-Smith; Sara Bokelund-Singh; Mohamed Sagar; Péter Nagy
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

4.  Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease.

Authors:  Naomi Uemura; Hideto Inokuchi; Hiroshi Serizawa; Toshiharu Chikama; Masao Yamauchi; Tomomi Tsuru; Toru Umezu; Toshiro Urata; Nobuo Yurino; Satoshi Tanabe; Tomoharu Yoshida; Susumu Kawamura; Atsushi Murakami; Munemitsu Yamamoto; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

5.  Test-based exclusion diets in gastro-esophageal reflux disease patients: a randomized controlled pilot trial.

Authors:  Michele Caselli; Giovanni Zuliani; Francesca Cassol; Nadia Fusetti; Elena Zeni; Natalina Lo Cascio; Cecilia Soavi; Sergio Gullini
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study.

Authors:  John Birk; Ronald Pruitt; Gregory Haber; Isaac Raijman; Arthur Baluyut; Mick Meiselman; Shahriar Sedghi
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

7.  Understanding gastro-oesophageal reflux disease: a patient-cluster analysis.

Authors:  A King; C MacDonald; C Orn
Journal:  Int J Clin Pract       Date:  2008-12       Impact factor: 2.503

8.  Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study.

Authors:  Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Nuevo
Journal:  Health Qual Life Outcomes       Date:  2009-10-16       Impact factor: 3.186

9.  Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting.

Authors:  Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Zapardiel
Journal:  Health Qual Life Outcomes       Date:  2009-07-02       Impact factor: 3.186

10.  Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study.

Authors:  Thirumazhisai Gunasekaran; Vasundhara Tolia; Richard B Colletti; Benjamin D Gold; Barry Traxler; Marta Illueca; Joseph A Crawley
Journal:  BMC Gastroenterol       Date:  2009-11-18       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.